Compare FDC LTD. with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SUN PHARMA FDC LTD./
SUN PHARMA
 
P/E (TTM) x 16.2 27.3 59.5% View Chart
P/BV x 2.2 2.4 93.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 FDC LTD.   SUN PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
SUN PHARMA
Mar-19
FDC LTD./
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs319679 47.0%   
Low Rs164375 43.7%   
Sales per share (Unadj.) Rs61.6121.1 50.9%  
Earnings per share (Unadj.) Rs9.913.4 74.4%  
Cash flow per share (Unadj.) Rs12.020.7 57.8%  
Dividends per share (Unadj.) Rs02.75 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs73.2172.6 42.4%  
Shares outstanding (eoy) m174.402,399.26 7.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.94.4 90.0%   
Avg P/E ratio x24.339.4 61.6%  
P/CF ratio (eoy) x20.225.5 79.2%  
Price / Book Value ratio x3.33.1 108.1%  
Dividend payout %020.6 0.0%   
Avg Mkt Cap Rs m42,1181,264,650 3.3%   
No. of employees `0005.517.5 31.6%   
Total wages/salary Rs m2,16759,671 3.6%   
Avg. sales/employee Rs Th1,943.716,608.1 11.7%   
Avg. wages/employee Rs Th391.73,409.6 11.5%   
Avg. net profit/employee Rs Th313.71,833.8 17.1%   
INCOME DATA
Net Sales Rs m10,751290,659 3.7%  
Other income Rs m51010,255 5.0%   
Total revenues Rs m11,260300,914 3.7%   
Gross profit Rs m2,26763,076 3.6%  
Depreciation Rs m35117,533 2.0%   
Interest Rs m145,553 0.3%   
Profit before tax Rs m2,41150,246 4.8%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m6716,009 11.2%   
Profit after tax Rs m1,73532,093 5.4%  
Gross profit margin %21.121.7 97.2%  
Effective tax rate %27.812.0 232.8%   
Net profit margin %16.111.0 146.2%  
BALANCE SHEET DATA
Current assets Rs m7,213310,692 2.3%   
Current liabilities Rs m2,104173,396 1.2%   
Net working cap to sales %47.547.2 100.6%  
Current ratio x3.41.8 191.3%  
Inventory Days Days5499 55.0%  
Debtors Days Days28112 24.9%  
Net fixed assets Rs m6,865232,477 3.0%   
Share capital Rs m1752,399 7.3%   
"Free" reserves Rs m12,586411,691 3.1%   
Net worth Rs m12,761414,091 3.1%   
Long term debt Rs m615,226 0.0%   
Total assets Rs m15,041646,938 2.3%  
Interest coverage x173.210.0 1,723.7%   
Debt to equity ratio x00 1.3%  
Sales to assets ratio x0.70.4 159.1%   
Return on assets %11.65.8 199.8%  
Return on equity %13.67.8 175.4%  
Return on capital %19.010.2 186.4%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88966,025 2.9%   
Fx outflow Rs m038,610 0.0%   
Net fx Rs m1,88927,415 6.9%   
CASH FLOW
From Operations Rs m1,49821,965 6.8%  
From Investments Rs m201-6,813 -3.0%  
From Financial Activity Rs m-1,694-27,305 6.2%  
Net Cashflow Rs m10-8,442 -0.1%  

Share Holding

Indian Promoters % 68.9 63.7 108.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 5.1 91.6%  
FIIs % 7.5 23.0 32.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.3 228.9%  
Shareholders   23,730 133,026 17.8%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 22, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS